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Abstract
Background: The relationship of cholesterol homeostasis and carotid intima-media thickness (cIMT) is unknown. To address
this, we assessed markers of cholesterol homeostasis (serum plant sterols and cholesterol precursor concentrations as
surrogate measures of cholesterol absorption and synthesis, respectively) and cIMT in a middle-aged, statin-naive
population.
Methods: In this prospective study of primary prevention cIMT was measured by ultrasound in 583 hospital employees
aged 25–60 years without prevalent cardiovascular disease or lipid-modifying medication. The serum concentrations of
plant sterols (as markers of cholesterol absorption) were measured by gas-liquid chromatography. Lathosterol serum
concentrations were quantitated to assess hepatic cholesterol synthesis.
Results: cIMT correlated positively with serum cholesterol (r = 0.22, P,0.0005) and lathosterol-to-cholesterol (r = 0.18,
P,0.001). In contrast, plant sterols, as markers of cholesterol absorption, showed a weak negative correlation to cIMT
measurements (r =20.18; P,0.001 for campesterol-to-cholesterol). Stratifying subjects by serum sterol levels, we found that
cIMT increased continuously over quintiles of serum cholesterol (P,0.0005) and was positively associated to serum
lathosterol-to-cholesterol levels (P = 0.007), on the other hand, plant sterol levels showed a weak negative association to
cIMT (P,0.001 for campesterol-to-cholesterol).
Conclusions: In this population without prevalent cardiovascular diseases or lipid-modifying medication, markers of
increased endogenous cholesterol synthesis correlated positively with cIMT, while markers of cholesterol absorption
showed a weakly negative correlation. These data suggest that not only total serum cholesterol levels but also differences in
cholesterol homeostasis are associated with cIMT.
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Introduction
Plasma cholesterol is derived from enteral cholesterol absorp-
tion and hepatic cholesterol synthesis,[1–3] and represents a causal
factor for the development of atherosclerotic diseases [4,5]. Serum
concentrations of plant sterols that are exclusively of dietary origin,
such as sitosterol and campesterol, reflect the efficacy of cholesterol
absorption [3,6]. Lathosterol, an intermediate of cholesterol
synthesis, is a marker of hepatic cholesterol formation [1,2].
Clinical trials of primary and secondary prevention have clearly
demonstrated that inhibiting cholesterol synthesis with statin
treatment reduces the risk of cardiovascular events and mortality
[7,8]. In contrast, the effect of inhibition of cholesterol absorption
by plant sterol-supplemented functional foods (e.g. margarine
supplemented with plant sterol esters), by the NPC1L1-inhibitor
ezetimibe, or by the administration of bile acid resins for the
primary prevention of atherosclerotic lesion development is
unknown [9–13].
Ultrasound of the carotid arteries allows clinicians to detect the
development of atherosclerosis at an early stage. Measurements of
carotid intima-media-thickness (cIMT), which is a marker of future
cardiovascular events [14–17], have been applied to assess the
effectiveness of lipid-lowering treatments in vascular disease
[18,19]. However, the differential effects of cholesterol absorption
and synthesis on cIMT are unknown [20].
In the prospective I LIKE HOMe study (Inflammation,
Lipoprotein Metabolism, and Kidney Damage in early athero-
genesis—The Homburg Evaluation), we evaluated cholesterol
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absorption and synthesis in relation to cIMT in 583 middle-aged
hospital employees. Participants had no known cardiovascular
disease (CVD), and were not taking lipid-modifying medication [21].
Methods
Subjects
Healthcare workers at the Saarland University Hospital in
Homburg/Saar, Germany, aged 25–60 years who were scheduled
to undergo routine medical checkups were invited to have an
ultrasonographic examination of their carotid arteries. Participants
were excluded if they had prevalent CVD, diabetes mellitus, active
tumor disease, inflammatory/autoimmune disease requiring
systemic immunosuppressive treatment, stage 4 or stage 5 chronic
kidney disease, were strict vegetarians or were on any lipid-
modifying medications. Prevalent CVD was diagnosed in subjects
who had a history of myocardial infarction, coronary artery
angioplasty, stenting, bypass surgery, major stroke, carotid
endarterectomy, non-traumatic lower extremity amputation, lower
limb artery bypass surgery, or angioplasty. Subjects on antihyper-
tensive medication, hormone replacement therapy, or oral
contraceptives were allowed to enter the I LIKE HOMe study.
A total of 583 participants met these inclusion criteria and were
included in the analysis. Written informed consent was obtained
from all study participants. The study protocol was approved by
the Ethics Committee of the University of Saarland. A
standardized questionnaire was used to record patient histories
of smoking, diabetes, current drug intake, cardiovascular comor-
bidity, and premature onset of CVD in the family (defined as
myocardial infarction or stroke before the age of 60 years in first-
degree relatives). Anthropomorphometric measurements and
resting blood pressure were recorded. Body mass index (BMI)
was calculated as the individual’s body weight divided by their
height squared. Systolic blood pressure (SBP), diastolic blood
pressure (DBP), and heart rate were measured after 5 min of rest.
Mean blood pressure was calculated as DBP+ [(SBP-DBP)/3].
Participants were categorized as active smokers if they were
current smokers or had stopped smoking less than 1 month before
entry into the study. Individuals who had self-reported diabetes
mellitus, a non-fasting blood sugar level of .200 mg/dl, a fasting
blood sugar level of .126 mg/dl, or were currently using
hypoglycemic medication were categorized as diabetic and
excluded from the study.
Biochemical Analysis
Blood samples were taken from all subjects under standardized
conditions. Plasma glucose, creatinine, total cholesterol, and high-
density lipoprotein (HDL) cholesterol were obtained using
standard techniques. Gas chromatography-flame ionization anal-
ysis was performed for quantification of cholesterol and mass
spectrometry was performed for lathosterol and plant sterols as
described previously [22].
Carotid Ultrasound
The cIMT of the common carotid artery was measured from high-
resolution, two-dimensional ultrasound images obtained using a
linear-array 7.5 MHz transducer (Sonoline Siena, Siemens, Erlan-
gen, Germany). With the subject in a supine position and the head
slightly extended and turned in the opposite direction, longitudinal B-
mode images of the distal common carotid artery and the carotid
bulb were acquired and digitally stored for offline reading by a single
blinded investigator. The cIMT was defined as the distance between
the leading edge of the lumen interface and the media-adventitia
interface of the far wall. Three representative measurements were
calculated for the far wall of both common carotid arteries at
predefined positions (1.0, 2.0, and 3.0 cm proximal to the
bifurcation), and these six IMT readings were averaged to give the
mean common cIMT. The cIMT was not measured at the site of a
carotid plaque, which was defined as a focal thickening of the intima-
media complex $1.1 mm irrespective of echogenicity.
Statistical Analysis
Data management and statistical analyses were performed using
SPSS 13.0. Unless otherwise indicated, continuous data are
expressed as the mean 6 standard deviation (SD) and compared
by the Mann-Whitney U test. Categorical variables are presented as
the percentage of participants. Correlation coefficients were
calculated by the Spearman test. A value of P,0.05 was considered
statistically significant. Subjects were stratified into quintiles of serum
cholesterol and non-cholesterol sterol levels. We recorded data on
cIMT measurements, age, BMI, and lipid metabolism parameter
trends across increasing quintiles of cholesterol, lathosterol, campes-
terol, and sitosterol using one-way analysis of variance (ANOVA)
and partitioning the between-group sums of squares into trend
components. Multivariable regression analyses were performed to
further analyze markers of cholesterol metabolism in relation to
cIMT. The Sobel test was used to assess whether the association
between BMI and cIMT was partially mediated by lathosterol.
Results
Baseline Characteristics of Subjects Enrolled in the Study
The baseline characteristics of the 583 subjects enrolled in the
study are shown in Table 1. The participants included 376 females
(64.5%), 105 individuals with a family history of premature-onset
CVD (18.0%), and 181 current smokers (31.1%). According to the
Framingham risk score 94.5% of the total study population was
classified as ‘‘low cardiovascular risk’’.
The Relationship of cIMT to Subject Baseline
Characteristics
For the entire study cohort, cIMT was positively correlated with
BMI (r = 0.35, P,0.0005), age (r = 0.52, P,0.0005), mean blood
pressure (r = 0.40, P,0.0005), plasma low density lipoprotein
(LDL) cholesterol (r = 0.24, P,0.0005) and triglycerides (r = 0.21,
P,0.0005). The plasma level of HDL cholesterol was negatively
correlated to cIMT (r =20.19, P,0.0005). As a consequence, we
found a significant association between cIMT and Framingham
risk score-based categories of risk for coronary heart disease
(CHD) (Fig. 1).
The Relationship of Non-cholesterol Sterols to Clinical
Parameters
BMI was associated with non-cholesterol sterols and their ratios
to cholesterol. While sitosterol (r =20.25, P,0.0005), the
sitosterol-to-cholesterol ratio (r =20.34, P,0.0005), campesterol
(r =20.27, P,0.0005), and the campesterol-to-cholesterol ratio
(r =20.34, P,0.0005) were negatively correlated with BMI,
markers of endogenous cholesterol synthesis, lathosterol, and the
lathosterol-to-cholesterol ratio, showed a positive correlation with
BMI (r = 0.43, P,0.0005 and r = 0.42, P,0.0005, respectively).
Furthermore, blood pressure was positively correlated with
lathosterol (r = 0.36, P,0.0005) and lathosterol-to-cholesterol ratio
(r = 0.26, P,0.0005), but correlated only weakly, if at all, with
cholesterol absorption (sitosterol r =20.06, P = n.s.; sitosterol-to-
cholesterol r =20.22, P,0.0005; campesterol r =20.09, P,0.05;
campesterol-to-cholesterol r =20.22, P,0.0005). Age was weakly
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correlated with lathosterol (r = 0.22, P,0.005) and lathosterol-to-
cholesterol ratio (r = 0.10, P,0.012), but not with sitosterol or
campesterol. As a result, the Framingham risk score correlated with
lathosterol (r = 0.28, P,0.0005) and the lathosterol-to-cholesterol
ratio (r = 0.17, P,0.0005), but correlated only weakly, if at all, with
campesterol (r = 0.03, P= n.s.) and the campesterol-to-cholesterol
ratio (r =20.10; P,0.021) and sitosterol (r = 0.04, P= n.s.) and the
sitosterol-to-cholesterol ratio (r =20.20, P,0.004).
The Relationship of cIMT to Serum Cholesterol
There was a positive correlation between cIMT and serum
cholesterol level (r = 0.22 P,0.001). Stratifying subjects into quintiles
based on serum cholesterol level, we found that cIMT measurements
increased continuously over quintiles of serum cholesterol (P for trend;
P,0.0005) with subjects in quintiles 5 and 4 having higher cIMT
measurements than those in quintile 1 (0.4660.09 mm and
0.4460.09 mm vs. 0.4160.06 mm, P,0.005 and P,0.0005,
respectively; Fig. 2A). Further analysis of the distribution of subject
characteristics with serum cholesterol revealed that age increased
significantly across quintiles. However, in a partial correlation
analysis controlling for age, the association between cIMT and
cholesterol remained statistically significant. Moreover, BMI, lipid
subfractions (LDL cholesterol, HDL cholesterol, and triglycerides),
and all non-cholesterol sterols (campesterol, sitosterol, and lathosterol)
increased over the quintiles of serum cholesterol levels, while the non-
cholesterol sterol-to-cholesterol ratios did not (data not shown).
The Relationship of cIMT to Endogenous Cholesterol
Synthesis
cIMT measurements correlated positively with serum lathos-
terol (r = 0.25, P,0.001) and lathosterol-to-cholesterol ratio
(r = 0.18, P,0.001) as a surrogate for endogenous cholesterol
synthesis. The latter association was found in both men (r = 0.164;
p = 0.018) and women (r = 0.153; p = 0.003). After stratification
Table 1. Patient Characteristics.
Patient Characteristics Mean ± SD
N 583
Age (years) 4268
Male/Female 207/376
Current or ex-smoker 181
Family history 105
Body mass index (kg/m2) 25.064.4
Framingham risk score ,10% 94.50%
Framingham risk score 10–20% 5%
Framingham risk score .20 0.50%
Heart rate (per min) 73.7610.3
Mean blood pressure (mmHg) 100.0612.0
Serum glucose (mg/dl) 91.4615.3
Glomerular filtration rate (ml/min/1.73 m2) 86.7614.9
IMT (mm) 0.43060.077
Total cholesterol (mg/dl) 204.7637.2
LDL cholesterol (mg/dl) 112.9634.4
HDL cholesterol (mg/dl) 67.1617.0
Triglycerides (mg/dl) 119.9682.4
Lathosterol (mg/dl) 0.2960.13
Campesterol (mg/dl) 0.3960.19
Sitosterol (mg/dl) 0.2960.12
Lathosterol-to-cholesterol ratio (mg/mg) 1.3960.56
Campesterol-to-cholesterol ratio (mg/mg) 1.9160.85
Sitosterol-to-cholesterol ratio (mg/mg) 1.4260.52
doi:10.1371/journal.pone.0013467.t001
Figure 1. Intima-media thickness by categories of risk for coronary heart disease. Values are mean +/2 SEM.
doi:10.1371/journal.pone.0013467.g001
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into quintiles by serum lathosterol levels, cIMT measurements
increased continuously over quintiles of serum lathosterol (P for
trend; P,0.0005) with significantly higher values in quintiles 5 and
4 than in quintile 1 (0.4560.08 mm and 0.4460.07 mm vs.
0.4160.06 mm, P,0.005 and P,0.0005, respectively; Fig. 2B). A
similar relation could be observed after stratification into quintiles
by lathosterol-to-cholesterol levels (P for trend; P = 0.007; Fig. 3A).
Similarly, age increased across the quintiles of serum lathosterol.
Again, the association between cIMT and lathosterol remained
significant in a partial correlation analysis controlling for age.
Total cholesterol, LDL cholesterol, triglycerides, and BMI
increased over the lathosterol quintiles, while non-cholesterol
sterols (campesterol and sitosterol), their ratios to cholesterol, and
HDL cholesterol decreased (data not shown).
The Relationship of cIMT to Cholesterol Absorption
Markers
In contrast to serum cholesterol and the cholesterol precursor
lathosterol, serum levels of the plant sterol campesterol and the
campesterol-to-cholesterol ratio showed a weakly negative corre-
lation with cIMT (r =20.08, P,0.04, and r =20.18, P,0.001,
respectively). The absolute concentration of sitosterol did not
correlate with cIMT (r =20.05, P,0.27); the sitosterol-to-
cholesterol ratio showed a weakly negative correlation with cIMT
(r =20.17, P,0.0005). Again, the association of cIMT measure-
ments with the campesterol-to-cholesterol ratio and sitosterol-to-
cholesterol ratio were found in both men and women (data not
shown).
Carotid intima-media thickness did not differ significantly with
absolute campesterol or sitosterol levels after stratification into
quintiles by plant sterol levels (Fig. 2C and Fig. 2D), but showed a
weak negative correlation across quintiles of campesterol-to-
cholesterol (P for trend; P,0.001; Fig. 3B) and sitosterol-to-
cholesterol (P for trend; P,0.001; Fig. 3C). Across quintiles of both
cholesterol absorption markers, plasma levels of total cholesterol,
LDL cholesterol, and HDL cholesterol increased, while BMI,
serum lathosterol concentration and lathosterol-to-cholesterol
ratio decreased (data not shown).
Figure 2. Intima-media thickness measurements in relation to quintiles of serum cholesterol, lathosterol, campesterol and
sitosterol. A: Intima-media thickness measurements in relation to quintiles of serum cholesterol concentration (P,0.0005). Values are mean +/2
SEM. B: Intima-media thickness measurements in relation to quintiles of serum lathosterol concentration (P,0.0005). Values are mean +/2 SEM. C:
Intima-media thickness measurements in relation to quintiles of serum campesterol concentration. Values are mean +/2 SEM. D: Intima-media
thickness measurements in relation to quintiles of serum sitosterol concentration. Values are mean +/2 SEM.
doi:10.1371/journal.pone.0013467.g002
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Multivariable Regression Analysis of Markers of
Cholesterol Metabolism in Relation to cIMT
Multivariable regression analyses revealed that elevated serum
lathosterol and low serum campesterol and sitosterol are associated
with cIMT after adjusting for age and LDL-cholesterol (Table 2).
When BMI was also adjusted for, no marker of cholesterol
metabolism remained independently associated with cIMT.
Nonetheless, the Sobel test revealed that the impact of BMI on
cIMT is mediated by lathosterol. BMI remains independently
associated with cIMT after further adjustment for mean arterial
pressure. A final multivariable model which included all
parameters assessed failed to show an independent association
between cIMT and either BMI or lathosterol probably due to
multicollinearity of the diverse markers of lipid metabolism.
Discussion
The present data demonstrate that both total serum cholesterol
levels and markers for endogenous cholesterol synthesis correlate
positively with cIMT in a middle-aged statin-naı¨ve population. In
contrast, plant sterols used as markers of cholesterol absorption
showed a weakly negative correlation with cIMT. The reciprocal
relation of cholesterol synthesis and cholesterol absorption markers
further strengthens the data and suggests that not only total serum
cholesterol levels but also differences in cholesterol homeostasis are
associated with the development of atherosclerosis.
Carotid IMT is the most commonly used and best validated
ultrasound measure of early and intermediate stages of athero-
sclerosis, including in young populations without known
CVD.[23] In fact, evidence suggests that this association may be
particularly strong in younger individuals with low cardiovascular
risk [17]. Furthermore, cIMT measurements have been useful as a
surrogate parameter to assess treatment efficacy in lipid-lowering
trials [10,19].
In addition to serving as a marker molecule for enteral
cholesterol absorption, the understanding of autosomal recessive
sitosterolemia led to speculation that plant sterols per se represent
a cardiovascular risk factor [24,25]. Elevated plant sterol
concentrations, xanthomatosis, and premature, frequently lethal
atherosclerosis in young subjects are the most striking features in
patients with homozygous sitosterolemia. These features are due to
mutations of the gene locus for the ABCG5 and ABCG8 co-
transporters, which result in increased absorption and reduced
biliary elimination of all sterols [26,27]. The fact that patients with
this disease present with an aggressive vascular disease process
despite nearly normal cholesterol levels raised the question of
whether high phytosterol levels exert atherogenic effects [28]. This
hypothesis has been supported by the finding that plant sterols are
detected in atherosclerotic lesions from individuals with apparently
normal cholesterol absorption [29]. Furthermore, some epidemi-
ological studies suggest that increased cholesterol absorption with
upper normal plasma plant sterol concentrations might reflect
increased vascular risk in non-sitosterolemic subjects [30–37]. On
the other hand, other well performed studies do not show such an
association; neither a recent case-control study nested into the
EPIC Norfolk population study, nor data from the LASA study
demonstrated a positive relationship between plasma plant sterol
levels and cardiac risk [38,39].
The findings of our study imply that there is no positive
association between serum plant sterol concentrations and cIMT
measurements in a middle-aged population with low plant sterol
serum levels. However, this relation may be different in
populations with higher cardiovascular risk and in later stages of
CVD. Notably, in the first epidemiological study to report an
association of plant sterol levels and increased cardiovascular risk,
Glueck and colleagues have already found that this relation was
especially strong in individuals with a positive family history, high
serum cholesterol levels, and generally higher cardiovascular risk
[30]. Similar findings have been reported by Sudhop and
colleagues in patients scheduled for coronary artery bypass surgery
[32], and by Strandberg and colleagues in a population of home-
dwelling elderly individuals [34]. Another recently published
epidemiological study indicated that increased campesterol-to-
cholesterol and sitosterol-to–cholesterol ratios were associated with
coronary artery disease severity [35]. In the Framingham Off-
Spring Study, higher absorption marker concentrations and lower
synthesis markers were significant predictors of CVD [36], a
finding that is in line with data reported by our research group in
patients with known severe aortic stenosis [37]. Interestingly,
similar to Matthan and colleagues, we found that, in patients with
severe aortic stenosis and an average age of 70 years, cholesterol
homeostasis shifted towards high cholesterol absorption and low
cholesterol synthesis was a better predictor of concomitant
coronary artery disease than any other established cardiovascular
Figure 3. Intima-media thickness measurements in relation to quintiles of serum lathosterol-to-cholesterol, campesterol-to-
cholesterol and sitosterol-to-cholesterol. A: Intima-media thickness measurements in relation to quintiles of lathosterol-to-cholesterol
(P = 0.007). Values are mean +/2 SEM. B: Intima-media thickness measurements in relation to quintiles of campesterol-to-cholesterol (P,0.001). Values
are mean +/2 SEM. C: Intima-media thickness measurements in relation to quintiles of sitosterol-to-cholesterol (P,0.001). Values are mean +/2 SEM.
doi:10.1371/journal.pone.0013467.g003
Table 2. Multivariable regression analysis of cholesterol and markers of cholesterol metabolism in relation to cIMT.
Univariable
adjusted for LDL-c
and age
adjusted for LDL-c,
age and BMI
adjusted for LDL-c, age,
BMI and mean BP
adjusted for LDL-c, age, BMI,
mean BP, HDL-c and TG
B P-value B P-value B P-value B P-value B P-value
Lathosterol 0.221 ,0.001 0.088 0.026 0.023 0.582 0.003 0.950 20.004 0.910
Campesterol 20.055 0.187 20.068 0.077 20.006 0.885 20.004 0.916 0.029 0.483
Sitosterol 20.035 0.397 20.080 0.038 20.018 0.648 20.014 0.725 0.020 0.621
BMI 0.325 ,0.001 0.186 ,0.001 (not applicable) 0.096 0.018 0.050 0.233
B: standardized regression coefficient; P: level of significance. All values have been log-transformed prior to analysis.
LDL-c: low density lipoprotein cholesterol; HDL-c: high density lipoprotein cholesterol; BP: blood pressure; BMI: body mass index; TG: triglycerides.
doi:10.1371/journal.pone.0013467.t002
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risk factor. Furthermore, data from the PROCAM study
demonstrate that upper normal plant sterol serum levels do not
affect cardiovascular risk in individuals with low and intermediate
cardiovascular risk, but increase cardiovascular risk three-fold in
individuals in the highest tertile [33]. Therefore, Assmann and
colleagues concluded that plant sterols as a marker for increased
cholesterol absorption are associated with an increased cardiovas-
cular risk, especially in individuals who have an increased
cardiovascular risk according to the PROCAM score. In this
regard, the findings of this study are in line with PROCAM data
showing that serum plant sterol concentrations do not correlate
with preclinical atherosclerosis in individuals who have low
cardiovascular risk in primary prevention setting. Finally, Strand-
berg and colleagues followed mildly hypercholesterolemic but
otherwise healthy men for 22 years [40] and found that increased
serum levels of plant sterols were associated with strongly
decreased cardiovascular risk. Notably, the study population
assessed by Strandberg and colleagues was in their forties, similar
in age to the I LIKE HOMe participants, while cohort studies
reporting that high plant sterol levels predict adverse outcomes
recruited mostly older subjects. Strandberg and coworkers
therefore hypothesized that these controvert findings might be
due to selection, as susceptible individuals with high cholesterol
synthesis and low cholesterol absorption (which reflect metabolic
syndrome), as well as increased BMI, may die before reaching old
age. Therefore, Strandberg concluded that the relationship
between non-cholesterol sterols and cardiovascular risk might be
another example of ‘‘reverse epidemiology’’ [41]. This concept
states that factors harmful in earlier life – such as overweight (the
‘‘obesity paradox’’), blood pressure, and cholesterol – may
paradoxically appear beneficial in older age. The present study
population would therefore represent a phase in which higher
cholesterol absorption and lower cholesterol synthesis each appear
to be protective.
Limitations
The dietary habits of study participants were not controlled in
detail prior to study enrollment. We therefore cannot exclude that
variations in dietary habits influenced the amount of ingested plant
sterols. However, previous work has supported the notion that
even a vegetarian lifestyle does not have major effects on plasma
plant sterol concentrations [42]. Moreover, interpretation of the
data is complicated by the fact that cholesterol metabolism is
closely related to features of the metabolic syndrome and obesity
[43]. Additionally, lipoproteins of hepatic and intestinal origin
(specifically, apolipoprotein B100 and apolipoprotein B48) have
not been assessed in this study. Finally, a long-term follow-up is
needed to determine whether differences in cholesterol absorption
and synthesis markers correlate with clinical events.
Conclusions
In this middle-aged population without prevalent CVD or lipid
modifying medication, markers for endogenous cholesterol
synthesis, but not markers for cholesterol absorption, were
positively related to cIMT as a measurement for subclinical
atherosclerosis. Because clinical trials evaluating novel cardiovas-
cular therapies to reduce serum cholesterol levels use cIMT
measurements as surrogate endpoints, these findings are of
importance and may have to be considered in the design of
future clinical trials investigating this issue. Furthermore, these
data suggest that in a middle-aged population cholesterol
homeostasis shifted towards increased markers for cholesterol
synthesis, rather than cholesterol absorption (a constellation typical
for metabolic syndrome) is associated with increased cardiovascu-
lar risk.
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